LifeMD (LFMDP) Debt/Equity Ratio: History & Chart

LifeMD, Inc.(LFMDP)

Medical - Healthcare Information Services · New York City, NY

$23.35+0.49 (+2.14%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About LifeMD, Inc.

LifeMD, Inc. functions as a direct-to-patient telehealth enterprise, linking individuals with healthcare professionals throughout the United States for a diverse array of medical concerns. These services encompass everything from personalized concierge care to specialized fields such as men's sexual health and dermatology. The company operates a portfolio of distinct telehealth brands. ShapiroMD is dedicated to comprehensive hair loss solutions, offering virtual consultations, prescription medications, unique over-the-counter products, an FDA-approved medical device, and specialized compounded topical treatments for both male and female hair loss. RexMD provides virtual medical treatment from licensed providers for various men's health requirements. LifeMD Primary Care is a subscription-based, mobile-first platform delivering personalized virtual primary, urgent, and chronic care, integrating online consultations, prescription services, diagnostics, and imaging. Cleared focuses on customized treatments for allergy, asthma, and immunological conditions. Nava MD serves as a female-oriented tele-dermatology and skincare brand, facilitating virtual medical consultations with dermatologists and other experts. Beyond its healthcare focus, LifeMD also manages PDFSimpli, an online software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents. The company distributes its products and services directly to consumers, through e-commerce channels, and via third-party partner networks. Initially established in 1994 as Conversion Labs, Inc., the company officially rebranded to LifeMD, Inc. in February 2021. Its corporate headquarters are located in New York, New York.

New York City, NY

389 employees

www.lifemd.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Justin Schreiber

View full financials

LFMDP Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

0.76

DEBT TO EQUITY RATIO AVG TTM

-1.19

DEBT TO EQUITY RATIO AVG 3Y

-2.26

DEBT TO EQUITY RATIO AVG 5Y

-0.56

DEBT TO EQUITY RATIO AVG 10Y

-0.34

DEBT TO EQUITY RATIO AVG 15Y

-0.10

DEBT TO EQUITY RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+163.28%

CURRENT VS 3Y AVG

+133.43%

CURRENT VS 5Y AVG

+235.31%

CURRENT VS 10Y AVG

+323.94%

CURRENT VS 15Y AVG

+867.29%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

0.11

median of 774 covered companies

CURRENT VS SECTOR MEDIAN

+586.64%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
LifeMD, Inc. (LFMDP)	$159.22M	0.76	-1.19	-2.26	-0.56
Coherus Oncology, Inc. (CHRS)vs ›	$159.14M	0.62	0.66	0.66	2.14
PepGen Inc. (PEPG)vs ›	$159.78M	0.13	0.14	0.15	0.10
Minerva Neurosciences, Inc. (NERV)vs ›	$159.80M	N/A	0.00	0.00	0.00
Quanterix Corporation (QTRX)vs ›	$162.04M	0.14	0.12	0.12	0.11
Inogen, Inc. (INGN)vs ›	$156.22M	0.09	0.10	0.10	0.08
Neuronetics, Inc. (STIM)vs ›	$153.79M	4.85	3.51	2.39	1.92
Jyong Biotech Ltd. Ordinary Shares (MENS)vs ›	$153.58M	N/A	N/A	N/A	N/A
Nkarta, Inc. (NKTX)vs ›	$165.27M	0.30	0.22	0.24	0.18
OptimizeRx Corp. (OPRX)vs ›	$165.32M	0.15	0.24	0.19	0.13

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

LifeMD, Inc. (LFMDP)

$159.22M

0.76

-1.19

-2.26

-0.56

Coherus Oncology, Inc. (CHRS)vs ›

$159.14M

0.62

0.66

2.14

PepGen Inc. (PEPG)vs ›

$159.78M

0.13

0.14

0.15

0.10

Minerva Neurosciences, Inc. (NERV)vs ›

$159.80M

N/A

0.00

Quanterix Corporation (QTRX)vs ›

$162.04M

0.14

0.12

0.11

Inogen, Inc. (INGN)vs ›

$156.22M

0.09

0.10

0.08

Neuronetics, Inc. (STIM)vs ›

$153.79M

4.85

3.51

2.39

1.92

Jyong Biotech Ltd. Ordinary Shares (MENS)vs ›

$153.58M

N/A

Nkarta, Inc. (NKTX)vs ›

$165.27M

0.30

0.22

0.24

0.18

OptimizeRx Corp. (OPRX)vs ›

$165.32M

0.15

0.24

0.19

0.13

Debt to Equity Ratio FAQ

What is the debt to equity ratio for LifeMD, Inc. (LFMDP)?

The debt to equity ratio for LFMDP stock is 0.76.

Is LifeMD, Inc.'s debt to equity ratio high or low?

The debt to equity ratio of 0.76 is 235% above its 5-year average of -0.56, near the high end of its 5-year range (-23.55–5.40).

What is the TTM average debt to equity ratio for LifeMD, Inc. (LFMDP)?

The TTM average debt to equity ratio for LFMDP stock is -1.19.

What is the 3Y average debt to equity ratio for LifeMD, Inc. (LFMDP)?

The 3Y average debt to equity ratio for LFMDP stock is -2.26.

What is the 5Y average debt to equity ratio for LifeMD, Inc. (LFMDP)?

The 5Y average debt to equity ratio for LFMDP stock is -0.56.

What is the 10Y average debt to equity ratio for LifeMD, Inc. (LFMDP)?

The 10Y average debt to equity ratio for LFMDP stock is -0.34.

What is the 15Y average debt to equity ratio for LifeMD, Inc. (LFMDP)?

The 15Y average debt to equity ratio for LFMDP stock is -0.10.

DATE	DEBT TO EQUITY RATIO
2026-06-30	0.76
2026-03-31	0.41
2025-12-31	0.27
2025-09-30	4.96
2025-06-30	-12.37
2025-03-31	-10.78
2024-12-31	-4.58
2024-09-30	-3.26
2024-06-30	-4.95
2024-03-31	-23.55
2023-12-31	5.40
2023-09-30	-1.59
2023-06-30	-1.39
2023-03-31	-2.25
2022-12-31	-0.60
2022-09-30	0.36
2022-06-30	0.20
2022-03-31	0.10
2021-12-31	0.07
2021-09-30	-0.82
2021-06-30	-3.15
2021-03-31	0.25
2020-12-31	0.79
2020-09-30	-0.24
2020-06-30	-0.25
2020-03-31	-0.19
2019-12-31	-0.85
2019-09-30	-1.60
2019-06-30	-0.20
2019-03-31	1.14
2018-12-31	0.28
2018-09-30	0.00
2018-06-30	0.05
2018-03-31	0.00
2017-12-31	0.19
2017-09-30	0.09
2017-06-30	-0.50
2017-03-31	-0.02
2016-12-31	-0.58
2016-09-30	0.71
2016-06-30	0.36
2016-03-31	1.30
2015-12-31	1.00
2015-09-30	-0.78
2015-06-30	-0.59
2015-03-31	-0.68
2014-12-31	-0.19
2014-09-30	-2.21
2014-06-30	1.60
2014-03-31	0.34
2013-12-31	0.21
2013-09-30	0.25
2013-06-30	0.00
2013-03-31	0.00
2012-12-31	0.00
2012-09-30	0.00
2012-06-30	0.00
2012-03-31	0.00

DATE

DEBT TO EQUITY RATIO

2026-06-30

0.76

2026-03-31

0.41

2025-12-31

0.27

2025-09-30

4.96

2025-06-30

-12.37

2025-03-31

-10.78

2024-12-31

-4.58

2024-09-30

-3.26

2024-06-30

-4.95

2024-03-31

-23.55

2023-12-31

5.40

2023-09-30

-1.59

2023-06-30

-1.39

2023-03-31

-2.25

2022-12-31

-0.60

2022-09-30

0.36

2022-06-30

0.20

2022-03-31

0.10

2021-12-31

0.07

2021-09-30

-0.82

2021-06-30

-3.15

2021-03-31

0.25

2020-12-31

0.79

2020-09-30

-0.24

2020-06-30

-0.25

2020-03-31

-0.19

2019-12-31

-0.85

2019-09-30

-1.60

2019-06-30

-0.20

2019-03-31

1.14

2018-12-31

0.28

2018-09-30

0.00

2018-06-30

0.05

2018-03-31

0.00

2017-12-31

0.19

2017-09-30

0.09

2017-06-30

-0.50

2017-03-31

-0.02

2016-12-31

-0.58

2016-09-30

0.71

2016-06-30

0.36

2016-03-31

1.30

2015-12-31

1.00

2015-09-30

-0.78

2015-06-30

-0.59

2015-03-31

-0.68

2014-12-31

-0.19

2014-09-30

-2.21

2014-06-30

1.60

2014-03-31

0.34

2013-12-31

0.21

2013-09-30

0.25

2013-06-30

0.00

2013-03-31

0.00

2012-12-31

0.00

2012-09-30

0.00

2012-06-30

0.00

2012-03-31

0.00

Debt to Equity Ratio: 0.76

LFMDP Debt to Equity Ratio

LFMDP Average Debt to Equity Ratio Chart

LFMDP Current vs Average Debt to Equity Ratio Chart

LFMDP Debt to Equity Ratio Metrics

LFMDP Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

LFMDP Debt to Equity Ratio History

Related Metrics